CollPlant Biotechnologies Ltd. (CLGN)Healthcare | Biotechnology | Rehovot, Israel | NasdaqCM
0.36 USD
+0.07
(23.576%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.34 -0.02 (-0.016%) ⇩ (Aug. 28, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:59 a.m. EDT
The investment case for CollPlant Biotechnologies is fundamentally broken by a severe multi-year decline in both earnings and stock price. The company has endured four consecutive years of negative annual returns, with the trailing seven-year window showing a catastrophic 54% drop in value. Fundamentals are dire: revenue has collapsed by 96%, operating margins are negative 43%, and the company is burning cash with no path to profitability visible in the data. While the stock trades at a discount to book value, this is a classic value trap where the market has correctly priced the business as failing. There is no dividend to provide income, and the options market is screaming 'sell,' with massive put positioning suggesting investors are betting on further declines. The recent price action shows a slight bounce off lows, but without a turnaround in revenue or a restoration of profitability, this remains a high-risk speculative vehicle with no margin of safety. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.106068 |
| AutoARIMA | 0.106137 |
| MSTL | 0.127348 |
| AutoTheta | 0.135768 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 4.95 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.171 |
| Excess Kurtosis | 1.36 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 54.216 |
| Revenue per Share | 0.03 |
| Market Cap | 6,769,138 |
| Forward P/E | -0.92 |
| Beta | 0.68 |
| Website | https://collplant.com |
As of Aug. 22, 2026, 3:59 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside participation. Put open interest significantly exceeds call open interest across all expirations, with deep out-of-the-money puts holding the highest concentration of volume and open interest. This indicates a market consensus expecting further price deterioration, despite the current price hovering near its 52-week low.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8901515 |
| Address1 | Weizmann Science Park |
| Address2 | 4 Oppenheimer P.O. Box 4132 |
| All Time High | 24.26 |
| All Time Low | 0.27 |
| Ask | 0.3829 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 68,750 |
| Average Daily Volume3 Month | 63,808 |
| Average Volume | 63,808 |
| Average Volume10Days | 68,750 |
| Beta | 0.684 |
| Bid | 0.3193 |
| Bid Size | 1 |
| Book Value | 0.339 |
| City | Rehovot |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.358 |
| Current Ratio | 2.268 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.4127 |
| Day Low | 0.2637 |
| Debt To Equity | 54.216 |
| Display Name | CollPlant Biotechnologies |
| Dividend Date | 1,479,686,400 |
| Earnings Call Timestamp End | 1,742,997,600 |
| Earnings Call Timestamp Start | 1,742,997,600 |
| Earnings Timestamp End | 1,788,265,800 |
| Earnings Timestamp Start | 1,788,265,800 |
| Ebitda | -12,072,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.294 |
| Enterprise To Revenue | 9.127 |
| Enterprise Value | 3,550,524 |
| Eps Forward | -0.39 |
| Eps Trailing Twelve Months | -1.23 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 972 73 232 5602 |
| Fifty Day Average | 0.32906 |
| Fifty Day Average Change | 0.028940022 |
| Fifty Day Average Change Percent | 0.087947555 |
| Fifty Two Week Change Percent | -89.01515 |
| Fifty Two Week High | 3.18 |
| Fifty Two Week High Change | -2.822 |
| Fifty Two Week High Change Percent | -0.88742137 |
| Fifty Two Week Low | 0.2637 |
| Fifty Two Week Low Change | 0.0943 |
| Fifty Two Week Low Change Percent | 0.35760334 |
| Fifty Two Week Range | 0.2637 - 3.18 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,517,409,000,000 |
| Float Shares | 8,560,922 |
| Forward Eps | -0.39 |
| Forward P E | -0.9179488 |
| Free Cashflow | -6,678,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 39 |
| Fullday Change | 0.0683 |
| Fullday Change Percent | 23.5761 |
| Fullday Price | 0.3419 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -1.47558 |
| Gross Profits | -574,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.29794002 |
| Held Percent Institutions | 0.099300005 |
| Implied Shares Outstanding | 18,908,207 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound care product for the treatment of deep surgical incisions and deep wounds. It also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. The company has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel. |
| Long Name | CollPlant Biotechnologies Ltd. |
| Market | us_market |
| Market Cap | 6,769,138 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_25715728 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -13,134,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 5,477,707 |
| Open | 0.2891 |
| Operating Cashflow | -11,301,000 |
| Operating Margins | -42.67123 |
| Payout Ratio | 0.0 |
| Phone | 972 73 232 5600 |
| Post Market Change | -0.01610002 |
| Post Market Change Percent | -4.497212 |
| Post Market Price | 0.3419 |
| Post Market Time | 1,787,961,545 |
| Previous Close | 0.2897 |
| Price Hint | 4 |
| Price To Book | 1.0560473 |
| Price To Sales Trailing12 Months | 17.401382 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.841 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0683 |
| Regular Market Change Percent | 23.5761 |
| Regular Market Day High | 0.4127 |
| Regular Market Day Low | 0.2637 |
| Regular Market Day Range | 0.2637 - 0.4127 |
| Regular Market Open | 0.2891 |
| Regular Market Previous Close | 0.2897 |
| Regular Market Price | 0.358 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 8,208,242 |
| Return On Assets | -0.61337 |
| Return On Equity | -1.51988 |
| Revenue Growth | -0.964 |
| Revenue Per Share | 0.03 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 18,908,207 |
| Shares Percent Shares Out | 0.0011999999 |
| Shares Short | 21,907 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 16,240 |
| Short Name | CollPlant Biotechnologies Ltd. |
| Short Percent Of Float | 0.0015 |
| Short Ratio | 0.4 |
| Source Interval | 15 |
| Symbol | CLGN |
| Total Cash | 4,262,000 |
| Total Cash Per Share | 0.295 |
| Total Debt | 2,649,000 |
| Total Revenue | 389,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.23 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.828305 |
| Two Hundred Day Average Change | -0.470305 |
| Two Hundred Day Average Change Percent | -0.56779206 |
| Type Disp | Equity |
| Volume | 8,208,242 |
| Website | https://collplant.com |
| Zip | 7,670,104 |